2.23 Covalent Inhibition of Btk with Clinical Development...

Clinical Lymphoma Myeloma and Leukemia 2011 Vol. 11; Iss. supp-S2

2.23 Covalent Inhibition of Btk with Clinical Development Compound AVL-292 Disrupts Signaling That Maintains the Microenvironment Necessary for Chronic Lymphocytic Leukemia Growth

E. Evans, S. Ponader, R. Karp, R. Tester, M. Sheets, S. Aslanian, T. St. Martin, M. Nacht, Z. Zhu, P. Chaturvedi, S. Witowski, H. Lounsbury, K. Stiede, J. Burger, R. Petter, J. Singh, W.F. Westlin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.09.056
File:
PDF, 74 KB
english, 2011
Conversion to is in progress
Conversion to is failed